Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines

References

• Aihara H, Miyazaki J. 1998. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16: 867–870.
   PubMedGoogle Scholar
• Alpar HO, Somavarapu S, Atuah KN, Bramwell V. 2005. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv Drug Delivery Rev 57: 411–430.
   PubMedGoogle Scholar
• Ando S, Putnam D, Pack DW, Langer R. 1999. PLGA microspheres containing plasmid DNA: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J Pharm Sci 88: 126–130.
   PubMedGoogle Scholar
• Anspach FB. 2001. Endotoxin removal by affinity sorbents. J Biochem Biophys Methods 49: 665–681.
   PubMedGoogle Scholar
• Arakawa T, Ejima D, Tsumoto K, Ishibashi M, Tokunaga M. 2007. Improved performance of column chromatography by arginine: Dye-affinity chromatography. Protein Expression Purif 52: 410–414.
   PubMedGoogle Scholar
• Bailey JE, Ollis DF. 1986. Biochemical Engineering Fundamentals. Singapore: McGraw-Hill.
   Google Scholar
• Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA. 2008. Emerging nanopharmaceuticals. Nanomed Nanotechnol Biol Med 4: 273–282.
   PubMedGoogle Scholar
• Bhattacharya S, Bajaj A. 2009. Advances in gene delivery through molecular design of cationic lipids. Chem Commun 4632–4656.
   PubMedGoogle Scholar
• Bivas-Benita M, van Meijgaarden KE, Franken K, Junginger HE, Borchard G, Ottenhoff THM, Geluk A. 2004. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of mycobacterium tuberculosis. Vaccine 22: 1609–1615.
   PubMedGoogle Scholar
• Bodles-Brakhop AM, Heller R, Draghia-Akli R. 2009. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: Current clinical developments. Mol Ther 17: 585–592.
   PubMedGoogle Scholar
• Borchard G. 2001. Chitosans for gene delivery. Adv Drug Deliv Rev 52: 145–150.
   PubMedGoogle Scholar
• Boyaka PN, Tafaro A, Fischer R, Fujihashi K, Jirillo E, McGhee JR. 2003. Therapeutic manipulation of the immune system: Enhancement of innate and adaptive mucosal immunity. Curr Pharm Des 9: 1965–1972.
   PubMedGoogle Scholar
• Buck ML. 2005. Combination measles, mumps, rubella, and varicella vaccine. Pediatr Pharm 11: 1–5.
   Google Scholar
• Bungay HR. 1963. Economic definition of continuous fermentation goals. Biotechnol Bioeng 5: 1–7.
   Google Scholar
• Canonico AE, Conary JT, Meyrick BO, Brigham KL. 1994. Aerosol and intravenous transfection of human alpha-1-antitrypsin gene to lungs of rabbits. Am J Respir Cell Mol Biol 10: 24–29.
   PubMedGoogle Scholar
• Carnes AE. 2008. Fermentation Process for Continuous Plasmid DNA Production. U.S. Patent 20080318283.
   Google Scholar
• Carnes AE. 2007. Process for Plasmid DNA Fermentation. U.S. Patent 20070254342.
   Google Scholar
• Carnes AE, Hodgson CP, Williams JA. 2006. Inducible Escherichia coli fermentation for increased plasmid DNA production. Biotechnol Appl Biochem 45: 155–166.
   PubMedGoogle Scholar
• Castagnoli L, Scarpa M, Kokkinidis M, Banner DW, Tsernoglou D, Cesareni G. 1989. Genetic and structural analysis of the ColE 1 Rop (Rom) protein. EMBO J 8: 621–629.
   PubMedGoogle Scholar
• Chen W. 1999. Automated High-Yield Fermentation of Plasmid DNA in Escherichia coli. U.S. Patent 5955323.
   Google Scholar
• Choi JS, Joo DK, Kim CH, Kim K, Park JS. 2000. Synthesis of a barbell-like triblock copolymer, poly(l-lysine) dendrimer-block-poly(ethylene glycol)-block-poly(l-lysine) dendrimer, and its self-assembly with plasmid DNA. J Am Chem Soc 122: 474–480.
   Google Scholar
• Chun KW, Lee JB, Kim SH, Park TG. 2005. Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels. Biomaterials 26: 3319–3326.
   PubMedGoogle Scholar
• Coban C, Ishii KJ, Gursel M, Klinman DM, Kumar N. 2005. Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors. J Leukoc Biol 778: 1–9.
   PubMedGoogle Scholar
• Córdoba LT, Bocanegra ARD, Llorente BR, Hernández ES, Echegoyen FB, Borja R, Bejines FR, Morcillo MFC. 2008. Batch culture growth of Chlorella zofingiensis on effluent derived from two-stage anaerobic digestion of two-phase olive mill solid waste. Electr J Biotech 11: 1–8.
   Google Scholar
• Corey L. 1999. HIV vaccines. Medscape HIV/AIDS 5: 1–3.
   Google Scholar
• Danquah MK, Forde GM. 2007a. Growth medium selection and its economic impact on plasmid DNA production. J Biosci Bioeng 104: 490–497.
   PubMedGoogle Scholar
• Danquah MK, Forde GM. 2008a. Large-volume methacrylate monolith for plasmid purification: Process engineering approach to synthesis and application. J Chromatogr A 1188: 227–233.
   PubMedGoogle Scholar
• Danquah MK, Forde GM. 2008b. Preparation of macroporous methacrylate monolithic material with convective flow properties for bioseparation: Investigating the kinetics of pore formation and hydrodynamic performance. Chem Eng J 140: 593–599.
   Google Scholar
• Danquah MK, Forde GM. 2007b. The suitability of DEAE-Cl active groups on customized poly(GMA-co-EDMA) continuous stationary phase for fast enzyme-free isolation of plasmid DNA. J Chromatogr B 853: 38–46.
   PubMedGoogle Scholar
• Danquah MK, Forde GM. 2008c. Development of a pilot-scale bacterial fermentation for plasmid-based biopharmaceutical production using a stoichiometric medium. Biotechnol Bioprocess Eng 13: 1–10.
   Google Scholar
• Danquah MK, Ho J, Forde GM. 2007. Performance of R-N(R9)-R99 functionalised poly(glycidyl methacrylate-co-ethylene glycol dimethacrylate) monolithic sorbent for plasmid DNA adsorption. J Sep Sci 30: 2843–2850.
   PubMedGoogle Scholar
• de Lima MCP, Simoes S, Pires P, Faneca H, Duzgunes N. 2001. Cationic lipid–DNA complexes in gene delivery: From biophysics to biological applications. Adv Drug Deliv Rev 47: 277–294.
   Google Scholar
• de Vries RD, Stittelaar KJ, Osterhaus AD, de Swart RL. 2008. Measles vaccination: New strategies and formulations. Expert Rev Vaccines 7: 1215–1223.
   PubMedGoogle Scholar
• Diogo MM, Queiroz JA, Prazeres DMF. 2005. Chromatography of plasmid DNA. J Chromatogr A 1069: 3–22.
   PubMedGoogle Scholar
• Dufes C, Uchegbu IF, Schatzlein AG. 2005. Dendrimers in gene delivery. Adv Drug Deliv Rev 57: 2177–2202.
   PubMedGoogle Scholar
• Dupuis M, Denis-Mize K, Woo C, Goldbeck C, Selby MJ, Chen MC, Otten GR, Ulmer JB, Donnelly JJ, Ott G, McDonald DM. 2000. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol 165: 2850–2858.
   PubMedGoogle Scholar
• Edwards DA, Hanes J, Caponetti G, Hrkach J, BenJebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R. 1997. Large porous particles for pulmonary drug delivery. Science 276: 1868–1871.
   PubMedGoogle Scholar
• Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Felgner PL. 1994. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269: 2550–2561.
   PubMedGoogle Scholar
• Felgner PL. 1996. Improvements in cationic liposomes for in vivo gene transfer. Hum Gene Ther 7: 1791–1793.
   PubMedGoogle Scholar
• Filomena S, Passarinha L, Sousa F, Queiroz JA, Domingues FC. 2009. Influence of growth conditions on plasmid DNA production. J Microbiol Biotechnol 19: 1408–1414.
   PubMedGoogle Scholar
• Freitas SS, Santos AL, Prazeres DMF. 2009. Plasmid purification by hydrophobic interaction chromatography using sodium citrate in the mobile phase. Sep Purif Tech 65: 95–104.
   Google Scholar
• Fukunaka Y, Iwanaga K, Morimoto K, Kakemi M, Tabata Y. 2002. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J Control Release 80: 333–343.
   PubMedGoogle Scholar
• Furuichi K, Katakura Y, Ninomiya K, Shioya S. 2007. Enhancement of 1,4-dihydroxy-2-naphthoic acid production by Propionibacterium freudenreichii ET-3 fed-batch culture. Appl Environ Microbiol 73: 3137–3143.
   PubMedGoogle Scholar
• Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. 1993. DNA vaccines—Protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 90: 11478–11482.
   PubMedGoogle Scholar
• Garmory HS, Brown KA, Titball RW. 2003. DNA vaccines: Improving expression of antigens. Genet Vaccines Ther 1: 1–5.
   PubMedGoogle Scholar
• Genton B. 2008. Malaria vaccines: A toy for travelers or a tool for eradication? Expert Rev Vaccines 7: 597–611.
   PubMedGoogle Scholar
• Ghosh P, Han G, De M, Kim CK, Rotello VM. 2008. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 60: 1307–1315.
   PubMedGoogle Scholar
• Glenting J, Wessels S. 2005. Ensuring safety of DNA vaccines. Microb Cell Factories 4: 26–30.
   PubMedGoogle Scholar
• Godbey WT, Wu KK, Mikos AG. 2001. Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials 22: 471–480.
   PubMedGoogle Scholar
• Gorman CM, Aikawa M, Fox B, Fox E, Lapuz C, Michaud B, Nguyen H, Roche E, Sawa T, WienerKronish JP. 1997. Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid edmpc. Gene Ther 4: 983–992.
   PubMedGoogle Scholar
• Goula D, Benoist C, Mantero S, Merlo G, Levi G, Demeneix BA. 1998. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther 5: 1291–1295.
   PubMedGoogle Scholar
• Goya AK, Khatri K, Mishra N, Vyas SP. 2008. New patents on mucosal delivery of vaccines. Expert Opin Ther Pat 18: 1271–1288.
   Google Scholar
• Gupta AK, Gupta M. 2005. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26: 1565–1573.
   PubMedGoogle Scholar
• Han Y, Forde GM. 2008. Single step purification of plasmid DNA using peptide ligand affinity chromatography. J Chromatogr B 874: 21–26.
   PubMedGoogle Scholar
• Harrison RG, Todd PW, Rudge SR, Petrides D. 2002. Bioseparations Science and Engineering. Oxford University Press, UK.
   Google Scholar
• Hartmann G, Krieg AM. 2000. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 164: 944–953.
   PubMedGoogle Scholar
• Hedley ML, Curley J, Urban R. 1998. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat Med 4: 365–368.
   PubMedGoogle Scholar
• Helson R, Olszewska W, Singh M, Megede JZ, Melero JA, Hagan DO, Openshaw PJM. 2008. Polylactide-co-glycolide (plg) microparticles modify the immune response to DNA vaccination. Vaccine 26: 753–761.
   PubMedGoogle Scholar
• Henke A. 2000. DNA immunization—A new chance in vaccine research? Med Microbiol Immunol 191: 187–190.
   Google Scholar
• Ho J, Wang HT, Forde GM. 2008. Process considerations related to the microencapsulation of plasmid DNA via ultrasonic atomization. Biotechnol Bioeng 101: 172–181.
   PubMedGoogle Scholar
• Hofland HEJ, Nagy D, Liu JJ, Spratt K, Lee YL, Danos O, Sullivan SM. 1997. In vivo gene transfer by intravenous administration of stable cationic lipid DNA complex. Pharm Res 14: 742–749.
   PubMedGoogle Scholar
• Hofland HEJ, Shephard L, Sullivan SM. 1996. Formation of stable cationic lipid/DNA complexes for gene transfer. Proc Natl Acad Sci U S A 93: 7305–7309.
   PubMedGoogle Scholar
• Holmgren J, Czerkinsky C. 2005. Mucosal immunity and vaccines. Nat Med 11: S45–S53.
   Google Scholar
• http://www.wiley.co.uk/genmed/clinical/. Gene therapy clinical trials worldwide. Wiley.
   Google Scholar
• Huang Y, Krasnitz M, Rabadan R, Witten DM, Song Y, Levine AJ, Ho DD, Robins H. 2008. A recoding method to improve the humoral immune response to an HIV DNA vaccine. PLoS ONE 3: 3214–3218.
   Google Scholar
• Huber H, Buchinger W, Diewok J, Ganja R, Keller D, Urthaler J, Necina R. 2008. Industrial manufacturing of plasmid DNA:Boehringer’s new cGMP production system employs prudent vector design as a backbone. Genet Eng Biotechnol News 28: 4–6.
   Google Scholar
• Huth S, Lausier J, Gersting SW, Rudolph C, Plank C, Welsch U, Rosenecker J. 2004. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med 6: 923–936.
   PubMedGoogle Scholar
• Hyde SC, Pringle IA, Abdullah S, Lawton AE, Davies LA, Varathalingam A, Nunez-Alonso G, Green AM, Bazzani RP, Sumner-Jones SG, Chan M, Li H, Yew NS, Cheng SH, Boyd AC, Davies JC, Griesenbach U, Porteous DJ, Sheppard DN, Munkonge FM, Alton E, Gill DR. 2008. Cpg-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat Biotechnol 26: 549–551.
   PubMedGoogle Scholar
• Jones DH, Corris S, McDonald S, Clegg JCS, Farrar GH. 1996. Poly(dl-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Proceedings of the International Meeting on Nucleic Acid Vaccines for the Prevention of Infectious Diseases. Bethesda, MD.
   Google Scholar
• Kakizawa Y, Kataoka K. 2002. Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev 54: 203–222.
   PubMedGoogle Scholar
• Kang HC, Lee M, Bae YH. 2005. Polymeric gene carriers. Crit Rev Eukaryot Gene Expr 15: 317–342.
   PubMedGoogle Scholar
• Kendall M. 2006. Engineering of needle-free physical methods to target epidermal cells for DNA vaccination. Vaccine 24: 4651–4656.
   PubMedGoogle Scholar
• Kievit FM, Veiseh O, Bhattarai N, Fang C, Gunn JW, Lee D, Ellenbogen RG, Olson JM, Zhang MQ. 2009. PEI–PEG–chitosan-copolymer-coated iron oxide nanoparticles for safe gene delivery: Synthesis, complexation, and transfection. Adv Func Mater 19: 2244–2251.
   PubMedGoogle Scholar
• Kim A, Checkla DM, Dehazya P, Chen WL. 2003. Characterization of DNA–hyaluronan matrix for sustained gene transfer. J Control Release 90: 81–95.
   PubMedGoogle Scholar
• Ko HJ, Ko SY, Kim YJ, Lee EG, Cho SN, Kang CY. 2005. Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B. Infect Immun 73: 5666–5674.
   PubMedGoogle Scholar
• Kong S, Rock CF, Booth A, Willoughby N, O’Kennedy RD, Relton J, Ward JM, Hoare M, Levy MS. 2008. Large-scale plasmid DNA processing: Evidence that cell harvesting and storage methods affect yield of supercoiled plasmid DNA. Biotechnol Appl Biochem 51: 43–51.
   PubMedGoogle Scholar
• Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu-Uvin S, Neutra MR. 2002. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: Influence of the menstrual cycle. J Immunol 169: 566–574.
   PubMedGoogle Scholar
• KukowskaLatallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR. 1996. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci U S A 93: 4897–4902.
   PubMedGoogle Scholar
• Kushibiki T, Tomoshige R, Fukunaka Y, Kakemi M, Tabata Y. 2003. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. J Control Release 90: 207–216.
   PubMedGoogle Scholar
• Kushibiki T, Tomoshige R, Iwanaga K, Kakemi M, Tabata Y. 2006. Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds. J Control Release 112: 249–256.
   PubMedGoogle Scholar
• Kutzler MA, Weiner DB. 2008. DNA vaccines: Ready for prime time? Nat Rev Genet 9: 776–788.
   PubMedGoogle Scholar
• Lechmann M, Liang TJ. 2000. Vaccine development for hepatitis C. Semin Liver Dis 20: 211–226.
   PubMedGoogle Scholar
• Lemmens R, Olsson U, Nyhammar T, Stadler J. 2003. Supercoiled plasmid DNA: Selective purification by thiophilic/aromatic adsorption. J Chromatogr B 784: 291–300.
   PubMedGoogle Scholar
• Levy MS, O’Kennedy RD, Shamlou PA, Dunnill P. 2000. Biochemical engineering approaches to the challenges of producing pure plasmid DNA. Tibtech 18: 296–304.
   PubMedGoogle Scholar
• Li GP, Liu ZG, Liao B, Zhong NS. 2009. Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice. Cell Mol Immunol 6: 45–50.
   PubMedGoogle Scholar
• Li PC, Li D, Zhang LX, Li GP, Wang EK. 2008. Cationic lipid bilayer coated gold nanoparticles-mediated transfection of mammalian cells. Biomaterials 29: 3617–3624.
   PubMedGoogle Scholar
• Li S, Tan YD, Viroonchatapan E, Pitt BR, Huang L. 2000. Targeted gene delivery to pulmonary endothelium by anti-pecam antibody. Am J Physiol-Lung Cell Mol Physiol 278: L504–L511.
   Google Scholar
• Li ZH, Ning W, Wang JM, Choi A, Lee PY, Tyagi P, Huang L. 2003. Controlled gene delivery system based on thermosensitive biodegradable hydrogel. Pharm Res 20: 884–888.
   PubMedGoogle Scholar
• Lindner LH, Brock R, Arndt-Jovin D, Eibl H. 2006. Structural variation of cationic lipids: Minimum requirement for improved oligonucleotide delivery into cells. J Control Release 110: 444–456.
   PubMedGoogle Scholar
• Listner K, Bentley L, Okonkowski J, Kistler C, Wnek R, Caparoni A, Junker B, Robinson D, Salmon P, Chartrain M. 2006. Development of a highly productive and scalable plasmid DNA production platform. Biotechnol Prog 22: 1335–1345.
   PubMedGoogle Scholar
• Liu F, Qi H, Huang L, Liu D. 1997. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther 4: 517–523.
   PubMedGoogle Scholar
• Liu L, Zhou X, Liu H, Xiang L, Yuan Z. 2005. CpG motif acts as a ‘danger signal’ and provides a T helper type 1-biased microenvironment for DNA vaccination. Immunology 115: 223–230.
   PubMedGoogle Scholar
• Liu MA. 2003. DNA vaccines: A review. J Intern Med 253: 402–410.
   PubMedGoogle Scholar
• Lu DM, Hickey AJ. 2007. Pulmonary vaccine delivery. Exp Rev Vaccines 6: 213–226.
   PubMedGoogle Scholar
• Luckay A, Sidhu MK, Kjeken R, Megati S, Siew-Yen C, Roopchand V, Garcia-Hand, D, Abdullah R, Braun R, Montefiori DC, Rosati M, Felber BK, Pavlakis GN, Mathiesen I, Israe ZR, Eldridge JH, Egan MA. 2007. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 81: 5257–5269.
   PubMedGoogle Scholar
• Lungwitz U, Breunig M, Blunk T, Gopferich A. 2005. Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm 60: 247–266.
   PubMed Web of Science ®Google Scholar
• Luo D, Saltzman WM. 2000. Synthetic DNA delivery systems. Nat Biotechnol 18: 33–37.
   PubMedGoogle Scholar
• Lynn DM, Langer R. 2000. Degradable poly(beta-amino esters): Synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc 122: 10761–10768.
   Web of Science ®Google Scholar
• Ma ZY, Guan YP, Liu HZ. 2005. Synthesis of monodisperse nonporous crosslinked poly(glycidyl methacrylate) particles with metal affinity ligands for protein adsorption. Polym Int >54: 1502–1507.
   Google Scholar
• MacLaughlin FC, Mumper RJ, Wang JJ, Tagliaferri JM, Gill I, Hinchcliffe M, Rolland AP. 1998. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release 56: 259–272.
   PubMedGoogle Scholar
• Magalhães PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TC, Pessoa A, Jr. 2007. Methods of endotoxin removal from biological preparations: A review. J Pharm Pharmaceut Sci 10: 388–404.
   PubMedGoogle Scholar
• Manoj S, Babiuk LA, Hurk DLS. 2004. Approaches to enhance the efficacy of DNA vaccines. Crit Rev Clin Lab Sci 41: 1–39.
   PubMedGoogle Scholar
• Manthorpe M, Cornefertjensen F, Hartikka J, Felgner J, Rundell A, Margalith M, Dwarki V. 1993. Gene-therapy by intramuscular injection of plasmid DNA—Studies on firefly luciferease gene-expression in mice. Hum Gene Ther 4: 419–431.
   PubMedGoogle Scholar
• May S, Harries D, Ben-Shaul A. 2000. The phase behavior of cationic lipid–DNA complexes. Biophys J 78: 1681–1697.
   PubMedGoogle Scholar
• McNeil SE, Perrie Y. 2006. Gene delivery using cationic liposomes. Exp Opin Ther Pat 16: 1371–1382.
   Google Scholar
• Meacle FJ, Zhang H, Papantoniou I, Ward JM, Titchener-Hooker NJ, Hoare M. 2007. Degradation of supercoiled plasmid DNA within a capillary device. Biotechnol Bioeng 97: 1148–1157.
   PubMedGoogle Scholar
• Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG. 2002. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 8: 415–419.
   PubMedGoogle Scholar
• Miyata K, Fukushima S, Nishiyama N, Yamasaki Y, Kataoka K. 2007. Peg-based block catiomers possessing DNA anchoring and endosomal escaping functions to form polyplex micelles with improved stability and high transfection efficacy. J Control Release 122: 252–260.
   PubMedGoogle Scholar
• Montgomery DL, Ulmer JB, Donnelly JJ, Liu MA. 1997. DNA vaccines. Pharmacol Ther 74: 195–205.
   PubMedGoogle Scholar
• Mutschlechner O, Swoboda H, Gapes JR. 2000. Continuous two-stage ABE-fermentation using Clostridium beijerinckii NRRL B592 operating with a growth rate in the first stage vessel close to its maximal value. J Mol Microbiol Biotechnol 2: 101–105.
   PubMedGoogle Scholar
• Nan XZ, He SW, Hao C, Lin CP. 2005. Effects of medium composition on the production of plasmid DNA vector potentially for human gene therapy. J Zhejiang Univ Sci 6B: 396–400.
   Google Scholar
• Nguyen DN, Green JJ, Chan JM, Longer R, Anderson DG. 2009. Polymeric materials for gene delivery and DNA vaccination. Adv Mater 21: 847–867.
   PubMedGoogle Scholar
• Nishiyama N, Kataoka K. 2006. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 112: 630–648.
   PubMedGoogle Scholar
• O’Hagan DT, Singh M, Ulmer JB. 2006. Microparticle-based technologies for vaccines. Methods 40: 10–19.
   PubMedGoogle Scholar
• Oishi M, Kataoka K, Nagasaki Y. 2006. Ph-responsive three-layered pegylated polyplex micelle based on a lactosylated abc triblock copolymer as a targetable and endosome-disruptive nonviral gene vector. Bioconjug Chem 17: 677–688.
   PubMedGoogle Scholar
• O’Kennedy R, Baldwin C, Moore EK. 2000. Effects of growth medium selection on plasmid DNA production and initial processing steps. J Biotechnol 76: 175–183.
   PubMedGoogle Scholar
• Ólafsdóttir G, Svansson V, Ingvarsson S, Marti E, Torsteinsdóttir S. 2008. In vitro analysis of expression vectors for DNA vaccination of horses: The effect of a Kozak sequence. Acta Vet Scand 50: 1–7.
   PubMedGoogle Scholar
• Ongkudon CM, Rahman BA, Aziz AA. 2006. Optimization of critical medium components for the expression of recombinant human transferrin in insect cells baculovirus system. J Teknologi F 45: 19–30.
   Google Scholar
• Ongkudon CM, Rahman BA, Aziz AA. 2005. Screening of the Sf900-II SFM insect cell culture medium recombinant baculovirus for the expression of recombinant human transferrin. Proceedings of the 15th MSMBB Scientific Meeting. Kuala Lumpur, Malaysia.
   Google Scholar
• Pan CH, Jimenez GS, Nair N, Wei Q, Adams RJ, Polack FP, Rolland A, Vilalta A, Griffin DE. 2008. Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus. Clin Vaccine Immunol 15: 1214–1221.
   PubMedGoogle Scholar
• Panyam J, Labhasetwar V. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55: 329–347.
   PubMedGoogle Scholar
• Park Y-C, Kim S-G, Park K, Lee KH, Seo J-H. 2004. Fed-batch production of d-ribose from sugar mixtures by transketolase-deficient Bacillus subtilis SPK1. Appl Microbiol Biotechnol 66: 297–302.
   Google Scholar
• Passarinha LA, Diogo MM, Queiroz JA, Monteiro GA, Fonseca LP, Prazeres DMF. 2006. Production of ColE1 type plasmid by Escherichia coli DH5α cultured under nonselective conditions. J Microbiol Biotechnol 16: 20–24.
   Google Scholar
• Patil SD, Rhodes DG, Burgessp DJ. 2005. DNA-based therapeutics and DNA delivery systems: A comprehensive review. AAPS 7: 61–77.
   Google Scholar
• Perrie Y, Frederik PM, Gregoriadis G. 2001. Liposome-mediated DNA vaccination: The effect of vesicle composition. Vaccine 19: 3301–3310.
   PubMedGoogle Scholar
• Pertmer TM, Eisenbraun MD, McCabe D, Prayaga SK, Fuller DF, Haynes JR. 1995. Gene-gun based nucleic-acid immunization—Elicitation of humoral and cytotoxic T-lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13: 1427–1430.
   PubMedGoogle Scholar
• Petersen H, Kunath K, Martin AL, Stolnik S, Roberts CJ, Davies MC, Kissel T. 2002. Star-shaped poly(ethylene glycol)-block-polyethylenimine copolymers enhance DNA condensation of low molecular weight polyethylenimines. Biomacromolecules 3: 926–936.
   PubMedGoogle Scholar
• Phue J-N, Lee SJ, Trinh L, Shiloach J. 2008. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5a). Biotechnol Bioeng 101: 831–836.
   PubMedGoogle Scholar
• Plank C, Schillinger U, Scherer F, Bergemann C, Remy JS, Krotz F, Anton M, Lausier J, Rosenecker J. 2003. The magnetofection method: Using magnetic force to enhance gene delivery. Biol Chem 384: 737–747.
   PubMedGoogle Scholar
• Pouton CW, Seymour LW. 2001. Key issues in non-viral gene delivery. Adv Drug Deliv Rev 46: 187–203.
   PubMedGoogle Scholar
• Prather KJ, Sagar S, Murphy J, Chartrain M. 2003. Industrial scale production of plasmid DNA for vaccine and gene therapy: Plasmid design, production, and purification. Enzyme Microb Technol 33: 865–883.
   Google Scholar
• Prazeres DMF, Ferreira GNM, Monteiro GA, Cooney CL, Cabral JMS. 1999. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: Problems and bottlenecks. Tibtech 17: 168–174.
   Google Scholar
• Rainczuk A, Scorza T, Spithill TW, Smooker PM. 2004. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria. Infect Immun 72: 5565–5573.
   PubMedGoogle Scholar
• Remaut E, Tsao H, Fiers W. 1983. Improved plasmid vectors with a thermoinducible expression and temperature-regulated runaway replication. Gene 22: 103–113.
   PubMedGoogle Scholar
• Robinson HL, Pertmer TM. 2000. DNA vaccines for viral infections: Basic studies and applications. Adv Virus Res 55:1–74.
   PubMedGoogle Scholar
• Romano G, Mitcheli P, Pacilio C, Giordano A. 2000. Latest developments in gene transfer technology: Achievements, perspectives, and controversies over therapeutic applications. Stem Cells 18: 19–39.
   PubMedGoogle Scholar
• Sahloff EG. 2005. Current issues in the development of a vaccine to prevent human immunodeficiency virus: Insights from the society of infectious diseases pharmacists. Pharmacotherapy 25: 741–747.
   PubMedGoogle Scholar
• Saldanha AJ, Brauer MJ, Botstein D. 2004. Nutritional homeostasis in batch and steady-state culture of yeast. Mol Biol Cell 15: 4089–4104.
   PubMedGoogle Scholar
• Scherer F, Anton M, Schillinger U, Henkel J, Bergemann C, Kruger A, Gansbacher B, Plank C. 2002. Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 9: 102–109.
   PubMedGoogle Scholar
• Segura T, Chung PH, Shea LD. 2005. DNA delivery from hyaluronic acid–collagen hydrogels via a substrate-mediated approach. Biomaterials 26: 1575–1584.
   PubMedGoogle Scholar
• Sheets EE, Urban RG, Crum CP, Hedley ML, Politch JA, Gold MA, Muderspach LI, Cole GA, Crowley-Nowick PA. 2003. Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 e7 plasmid DNA. Am J Obstet Gynecol 188: 916–926.
   PubMedGoogle Scholar
• Shroff KE, Smith LR, Baine Y, Higgins TJ. 1999. Potential for plasmid DNAs as vaccines for the new millennium. Pharm Sci Technol Today 2: 205–212.
   PubMedGoogle Scholar
• Shuler ML, Kargi F. 2002. Bioprocess Engineering Basic Concepts. Prentice Hall, USA.
   Google Scholar
• Schmidt T, Friehs K, Flaschel E, Schleef M. 2003. Method for the Isolation of CCC plasmid DNA. U.S. patent 6664078.
   Google Scholar
• Smith CR, DePrince RB, Dackor J, Weigl D, Griffith J, Persmark M. 2007. Separation of topological forms of plasmid DNA by anion-exchange HPLC: Shifts in elution order of linear DNA. J Chromatogr B 854: 121–127.
   PubMedGoogle Scholar
• Smith J, Zhang YL, Niven R. 1997. Toward development of a non-viral gene therapeutic. Adv Drug Deliv Rev 26: 135–150.
   PubMedGoogle Scholar
• Smith JM, Amara RR, McClure HM, Patel M, Sharma S, Yi H, Chennareddi L, Herndon JG, Butera ST, Heneine W, Ellenberger DL, Parekh B, Earl PL, Wyatt LS, Moss B, Robinson HL. 2004. Multiprotein HIV type 1 clade B DNA/MVA vaccine: Construction, safety, and immunogenicity in macaques. AIDS Res Hum Retroviruses 20: 654–665.
   PubMedGoogle Scholar
• Song MK, Vindurampulle CJ, Capozzo AVE, Ulmer J, Polo JM, Pasetti MF, Barry EM, Levine MM. 2005. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins. J Virol 79: 9854–9861.
   PubMedGoogle Scholar
• Sousa F, Duarte MF, Prazeres, Queiroz JA. 2008. Affinity chromatography approaches to overcome the challenges of purifying plasmid DNA. Trends Biotechnol 26: 518–525.
   PubMedGoogle Scholar
• Sousa F, Prazeres DMF, Queiroz JA. 2009a. Binding and elution strategy for improved performance of arginine affinity chromatography in supercoiled plasmid DNA purification. Biomed Chromatogr 23: 160–165.
   PubMedGoogle Scholar
• Sousa F, Prazeres DMF, Queiroz JA. 2009b. Improvement of transfection efficiency by using supercoiled plasmid DNA purified with arginine affinity chromatography. J Gene Med 11: 79–88.
   PubMedGoogle Scholar
• Stadler J, Lemmens R, Nyhammar T. 2004. Plasmid DNA purification. J Gene Med 6: 54–66.
   Google Scholar
• Stephan DJ, Yang ZY, San H, Simari RD, Wheeler CJ, Felgner PL, Gordon D, Nabel GJ, Nabel EG. 1996. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther 7: 1803–1812.
   PubMedGoogle Scholar
• Stern M, Ulrich K, Geddes DM, Alton E. 2003. Poly (d,l-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Gene Ther 10: 1282–1288.
   Google Scholar
• Tan L, Kim D-S, Yoo I-K, Choe W-S. 2007b. Harnessing metal ion affinity for the purification of plasmid DNA. Chem Eng Sci 62: 5809–5820.
   Google Scholar
• Tan L, Lai WB, Lee CT, Kim DS, Choe W-S. 2007a. Differential interactions of plasmid DNA, RNA and endotoxin with immobilised and free metal ions. J Chromatogr A 1141: 226–234.
   PubMedGoogle Scholar
• Tanaka N, Kobayashi H. 2003. Monolithic columns for liquid chromatography. Anal Bioanal Chem 376: 298–301.
   PubMedGoogle Scholar
• Tang DC, Devit M, Johnston SA. 1992. Genetic immunization is a simple method for eliciting an immune-response. Nature 356: 152–154.
   PubMedGoogle Scholar
• Thatcher DR, Hitchcock A, Hanak JAJ, Varley DL. 1999. Method of Plasmid DNA Production and Purification. U. S. patent 5981735.
   Google Scholar
• Thierry AR, Vives E, Richard JP, Prevot P, Martinand-Mari C, Robbins I, Lebleu B. 2003. Cellular uptake and intracellular fate of antisense oligonucleotides. Curr Opin Mol Ther 5: 133–138.
   PubMedGoogle Scholar
• Thomas M, Klibanov AM. 2003. Conjugation to gold nanoparticles enhances polyethylenimine’s transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A 100: 9138–9143.
   PubMedGoogle Scholar
• Turker S, Onur E, Ozer Y. 2004. Nasal route and drug delivery systems. Pharm World Sci 26: 137–142.
   PubMedGoogle Scholar
• Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, Dewitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgomery DL, Liu MA. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745–1749.
   PubMedGoogle Scholar
• United States Food Drug Administration (US FDA). 2007. Considerations for Plasmid DNA Vaccines for Infectious Disease Indications. Office of Vaccines Research Review. Rockville, USA.
   Google Scholar
• Urthaler J, Ascher C, Wöhrer H, Necina R. 2007. Automated alkaline lysis for industrial scale cGMP production of pharmaceutical grade plasmid-DNA. J Biotech 128: 132–149.
   PubMedGoogle Scholar
• Urthaler J, Buchinger W, Necina R. 2005a. Improved downstream process for the production of plasmid DNA for gene therapy. Acta Biochim Pol 52: 703–711.
   PubMedGoogle Scholar
• Urthaler J, Buchinger W, Necina R. 2005b. Industrial scale cGMP purification of pharmaceutical grade plasmid DNA. Chem Eng Technol 28: 1408–1420.
   Google Scholar
• Wagner E, Cotten M, Foisner R, Birnstiel ML. 1991. Transferrin polycation DNA complexes—The effect of polycations on the structure of the complex and DNA delivery to cells. Proc Natl Acad Sci U S A 88: 4255–4259.
   PubMedGoogle Scholar
• Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB. 1993. Gene inoculation generates immune-responses against human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 90: 4156–4160.
   PubMedGoogle Scholar
• Wang H, Chen Y, Li XY, Liu Y. 2007. Synthesis of oligo(ethylenediamino)-beta-cyclodextrin modified gold nanoparticle as a DNA concentrator. Mol Pharm 4: 189–198.
   PubMedGoogle Scholar
• Wang Z, Le G, Shi Y, Wegrzyn G. 2001. Medium design for plasmid DNA production based on stoichiometric model. Process Biochem 36: 1085–1093.
   Google Scholar
• Wheeler CJ, Felgner PL, Tsai YJ, Marshall J, Sukhu L, Doh SG, Hartikka J, Nietupski J, Manthorpe M, Nichols M, Plewe M, Liang XW, Norman J, Smith A, Cheng SH. 1996. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc Natl Acad Sci U S A 93: 11454–11459.
   PubMed Web of Science ®Google Scholar
• Wieland,JA, Houchin-Ray TL, Shea LD. 2007. Non-viral vector delivery from PEG–hyaluronic acid hydrogels. J Control Release 120: 233–241.
   PubMedGoogle Scholar
• Wigglesworth TJ, Teixeira F, Axthelm F, Eisler S, Csaba NS, Merkle HP, Meier W, Diederich F. 2008. Dendronised block copolymers as potential vectors for gene transfection. Org Biomol Chem 6: 1905–1911.
   PubMedGoogle Scholar
• Williams JA, Luke J, Langtry S, Anderson S, Hodgson CP, Carnes AE. 2009. Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes. Biotechnol Bioeng 103: 1129–1143.
   PubMedGoogle Scholar
• World Health Organization WHO. 2007. Guidelines for assuring the quality and nonclinical safety evaluation of DNA vaccines. World Health Organization. Geneva, Switzerland.
   Google Scholar
• Xiang JJ, Tang JQ, Zhu SG, Nie XM, Lu HB, Shen SR, Li XL, Tang K, Zhou M, Li GY. 2003. Ionp-pll: A novel non-viral vector for efficient gene delivery. J Gene Med 5: 803–817.
   PubMedGoogle Scholar
• Yao S, Helinsk DR, Toukdarian A. 2007. Localization of the naturally occurring plasmid ColE1 at the cell pole. J Bacteriol 189: 1946–1953.
   PubMedGoogle Scholar
• Yoshikawa T, Imazu S, Gao J-Q, Hayashi K, Tsuda Y, Okada N, Tsutsumi Y, Akashit M, Mayumi T, Nakagawa S. 2006. Non-methylated CpG motif packaged into fusogenic liposomes enhance antigen-specific immunity in mice. Biol Pharm Bull 29: 105–109.
   PubMedGoogle Scholar
• Zauner W, Ogris M, Wagner E. 1998. Polylysine-based transfection systems utilizing receptor-mediated delivery. Adv Drug Deliv Rev 30: 97–113.
   PubMedGoogle Scholar
• Zhang JP, Wang Q, Smith TR, Hurst WE, Sulpizio T. 2005. Endotoxin removal using a synthetic adsorbent of crystalline calcium silicate hydrate. Biotechnol Prog 21: 1220–1225.
   PubMedGoogle Scholar